Posted November 16, 2007

Medical Device, Sensor Startup Lands $11.3M

Print this story

On The Web

Centice, a medical device and diagnostics startup, has closed on $11.3 million in financing.

Among the investors is The Aurora Funds, which is based in Durham.

Centice has licensed technology developed at Duke University for use in spectroscopy, which is the study of the interaction between light and matter.

Its latest patent covers methods and systems for making spectral measurements on weak diffuse resources while at the same time maintaining high resolution.

Centice utilizes multimode multiplex spectroscopy developed at Duke. The technology has led to development of molecular analyzers with high sensitivity. Spectroscopy is used for material identification, quantitative analysis and quality control.

To date, Centice has applied for more than 20 patents.

The News & Observer reported the Centice funding on Friday.

Copyright 2010 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Venture & Innovation

Venture & Innovation

Stories about local business ventures and innovation. Read more articles…

Featured